Macular telangiectasia type 2 is a bilateral disease of unknown cause with characteristic
alterations of the macular capillary network and neurosensory atrophy. Its prevalence may …

purpose. To report the characteristics of confocal blue reflectance imaging in type 2
idiopathic macular telangiectasia (type 2 IMT). methods. In a prospective observational cross …

Purpose: To determine the distribution of macular pigment in type 2 idiopathic macular
telangiectasia (IMT). Methods: Twenty-two eyes of 12 patients with type 2 IMT were …

Recently, a unique distribution, namely a reduction of macular pigment optical density
(MPOD) within the central retina with a surrounding ring-like structure of preserved MPOD at …

purpose. Macular telangiectasia (MacTel) type 2 typically exhibits sharply demarcated
parafoveal scotomas. In an investigation of their significance for reading performance …

Most diseases causing increased autofluorescence do so because of a corresponding
increase in fluorophores in the retinal pigment epithelium (RPE). This chapter covers …

OBJECTIVE: To report findings in asymptomatic family members of patients with macular
telangiectasia type 2. DESIGN: Prospective, observational, cross-sectional case series …

PURPOSE: To investigate the efficacy and safety of intravitreal ranibizumab for the treatment
of nonproliferative macular telangiectasia (MacTel) type 2. DESIGN: Prospective, open …

Purpose To describe patients with full-thickness macular holes (FTMHs) and lamellar
macular holes (LMHs) in association with type 2 idiopathic macular telangiectasia (type 2 …

Aim: To evaluate the effects of intravitreal bevacizumab for non-proliferative type 2 idiopathic
macular telangiectasia (type 2 IMT) within a mean follow-up period of 18 months. Methods …